View in EDS

EE297 Pricing Strategies and Trends of FDA Approved NSCLC Therapies From 2018 to 2023.

Saved in:

Bibliographic Details
Title:	EE297 Pricing Strategies and Trends of FDA Approved NSCLC Therapies From 2018 to 2023.
Authors:	Cheng, SY¹ (AUTHOR), Ambegaonkar, AJ² (AUTHOR)
Source:	Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS112-S112. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	10983015
DOI:	10.1016/j.jval.2024.03.596